Eugene P. Kennedy - Sep 1, 2022 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
Chief Medical Officer
Signature
/s/ Christopher Degnan, Attorney-in-Fact for Eugene P. Kennedy
Stock symbol
GRTX
Transactions as of
Sep 1, 2022
Transactions value $
$0
Form type
4
Date filed
9/2/2022, 04:15 PM
Next filing
Feb 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +150K $0.00 150K Sep 1, 2022 Common Stock 150K $1.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 25% on September 1, 2023, and in thirty-six (36) substantially equal monthly installments over a three-year period thereafter.